Clinical Trials Directory

Trials / Completed

CompletedNCT02191020

Efficacy and Safety Study of Total Glucosides of Paeony Combined With Acitretin to Treat Psoriasis

Multi-center, Randomized, Double Blind, Placebo Parallel-Controlled Study of the Efficacy and Safety of Total Glucosides of Paeony Combined With Acitretin Capsules to Treat Psoriasis Vulgaris

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
108 (actual)
Sponsor
Xijing Hospital · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

This is a randomized, double blind, placebo parallel-controlled, multi-center clinical trial. Patients with psoriasis vulgaris were randomly divided into the experiment group (treated with TGP combined with acitretin capsules) and control group (treated with placebo combined with acitretin capsules).The treatment lasted 12 weeks. The efficacy and safety were evaluated at the baseline, as well as 2, 4, 8 and 12 weeks after the beginning of treatment.The investigator's hypothesis TGP combined with Acitretin Capsulesin is more safe and effective than Acitretin Capsulesin to treat Psoriasis Vulgaris.

Conditions

Interventions

TypeNameDescription
DRUGTotal glucosides of paeony & Acitretin Capsules
DRUGAcitretin Capsules

Timeline

Start date
2013-02-01
Primary completion
2013-10-01
Completion
2013-10-01
First posted
2014-07-15
Last updated
2014-07-15

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02191020. Inclusion in this directory is not an endorsement.